RAKIN KEVIN — SEC insider filings

SEC reporting owner CIK 1184421. 39 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 39 filings on record, filed 2020-10-13 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ELUTIA INC. (ELUT)Director, 10% owner218 legs · 4,966,039 sh · $13,891,433—26
ORAMED PHARMACEUTICALS INC. (ORMP)Director10—2 legs · 31,100 sh · $536,92622
Quantum-Si Inc (QSI)Director8—1 leg · 89,000 sh · $191,2348

Insider filings — RAKIN KEVIN

FiledFormIssuerReported transactionsSource
2026-11-124ELUTIA INC. (ELUT)Grant/award (A): 176,000 (derivative) @ $0EDGAR
2026-06-154ELUTIA INC. (ELUT)Grant/award (A): 159,590 (derivative) @ $0EDGAR
2026-06-024ELUTIA INC. (ELUT)
jointly with HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HighCape Partners QP II, L.P.
Gift (G): 70,000 @ $0 · Other (J): 50,000 @ $0EDGAR
2026-05-204Quantum-Si Inc (QSI)Grant/award (A): 251,185 (derivative) @ $0EDGAR
2026-02-024ELUTIA INC. (ELUT)
jointly with HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HighCape Partners QP II, L.P.
Purchase (P): 70,000 @ $1.06EDGAR
2025-12-194/AELUTIA INC. (ELUT)
jointly with HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC
Other (J): 4,505,941EDGAR
2025-12-194ELUTIA INC. (ELUT)
jointly with HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HighCape Partners QP II, L.P.
Purchase (P): 50,000 @ $0.52EDGAR
2025-12-174/AELUTIA INC. (ELUT)Other (J): 4,505,941EDGAR
2025-12-154ELUTIA INC. (ELUT)Other (J): 4,372,497EDGAR
2025-06-024ELUTIA INC. (ELUT)Grant/award (A): 90,509 (derivative) @ $0EDGAR
2025-05-214Quantum-Si Inc (QSI)Grant/award (A): 126,095 (derivative) @ $0EDGAR
2025-03-134ELUTIA INC. (ELUT)
jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Capital, LLC, HighCape Partners GP II, L.P., HighCape Co-Investment Vehicle I, LLC
Purchase (P): 420,000 @ $2.50EDGAR
2024-08-014ELUTIA INC. (ELUT)
jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P.
Option exercise/expiry (X): 2,101,577 @ $1.43 · Option exercise/expiry (X): 2,101,577 (derivative) @ $0EDGAR
2024-06-104ELUTIA INC. (ELUT)Grant/award (A): 47,753 (derivative) @ $0EDGAR
2024-05-174Quantum-Si Inc (QSI)Grant/award (A): 113,281 (derivative) @ $0EDGAR
2024-01-084ELUTIA INC. (ELUT)
jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P.
Other (J): 1,436,077 · Other (J): 2,154,116 (derivative)EDGAR
2023-10-054ELUTIA INC. (ELUT)
jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P.
Purchase (P): 2,837,128 · Purchase (P): 4,255,693 (derivative)EDGAR
2023-06-124AZIYO BIOLOGICS, INC. (AZYO)
jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt
Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-05-164Quantum-Si Inc (QSI)Grant/award (A): 120,481 (derivative) @ $0EDGAR
2022-12-274AZIYO BIOLOGICS, INC. (AZYO)
jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt
Grant/award (A): 17,533 (derivative) @ $0EDGAR
2022-12-224Quantum-Si Inc (QSI)Other (J): 601,000 @ $0EDGAR
2022-12-164Quantum-Si Inc (QSI)Sale (S): 89,000 @ $2.15EDGAR
2022-12-074AZIYO BIOLOGICS, INC. (AZYO)
jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt
Purchase (P): 735,000 @ $4.75EDGAR
2022-06-094AZIYO BIOLOGICS, INC. (AZYO)
jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt
Grant/award (A): 22,090 (derivative) @ $0 · Grant/award (A): 22,090 (derivative) @ $0EDGAR
2022-05-134Quantum-Si Inc (QSI)Grant/award (A): 59,880 (derivative) @ $0EDGAR
2022-03-224ORAMED PHARMACEUTICALS INC. (ORMP)Sale (S): 10,000 @ $9.41EDGAR
2022-02-224ORAMED PHARMACEUTICALS INC. (ORMP)Option exercise (M): 6,667 @ $4.80 · Tax withholding (F): 3,010 @ $10.63 · Option exercise (M): 6,667 (derivative) @ $0EDGAR
2022-02-154/AORAMED PHARMACEUTICALS INC. (ORMP)Gift (G): 5,000 @ $0EDGAR
2022-02-144ORAMED PHARMACEUTICALS INC. (ORMP)Gift (G): 5,000 @ $0EDGAR
2022-01-054ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 6,000 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-12-174ORAMED PHARMACEUTICALS INC. (ORMP)Gift (G): 5,000 @ $0EDGAR
2021-12-104AZIYO BIOLOGICS, INC. (AZYO)
jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt
Purchase (P): 353,773 @ $4.24 · Purchase (P): 58,962 @ $4.24EDGAR
2021-09-204ORAMED PHARMACEUTICALS INC. (ORMP)Sale (S): 21,100 @ $20.99EDGAR
2021-09-024ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 10,000EDGAR
2021-08-114ORAMED PHARMACEUTICALS INC. (ORMP)Option exercise (M): 5,697 @ $6.23 · Tax withholding (F): 1,683 @ $21.09 · Option exercise (M): 6,666 @ $4.80 · Tax withholding (F): 1,517 @ $21.09 · Option exercise (M): 10,000 @ $4.17 · Tax withholding (F): 1,977 @ $21.09 · +6 moreEDGAR
2021-06-154Quantum-Si Inc (QSI)Grant/award (A): 1,901,000 @ $10 · Grant/award (A): 20,512 @ $0EDGAR
2021-06-094AZIYO BIOLOGICS, INC. (AZYO)
jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt
Grant/award (A): 14,082 (derivative) @ $0 · Grant/award (A): 14,082 (derivative) @ $0EDGAR
2021-02-174ORAMED PHARMACEUTICALS INC. (ORMP)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2020-10-134AZIYO BIOLOGICS, INC. (AZYO)
jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt
Conversion (C): 4,062,451 @ $0 · Option exercise/expiry (X): 7,655 @ $5.44 · Tax withholding (F): 2,451 @ $5.44 · Purchase (P): 441,176 @ $17 · Conversion (C): 31,133,977 (derivative) @ $0 · Option exercise/expiry (X): 7,655 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1184421 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs